Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors

Genes Chromosomes and Cancer

Volumn 47, Issue 7, 2008, Pages 573-590

  Gabrea, Ana ^a   Martelli, Maria Luisa ^b   Qi, Ying ^a   Roschke, Anna ^a   Barlogie, Bart ^c   Shaughnessy Jr , John D ^c   Sawyer, Jeffrey R ^c   Kuehl, W Michael ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; MYC PROTEIN;

ARTICLE; CELL LINE; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DIPLOIDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMICS; HUMAN; HUMAN CELL; LIGHT CHAIN; MYELOMA; PREVALENCE; PRIORITY JOURNAL;

CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; DIPLOIDY; GENE REARRANGEMENT; GENES, IMMUNOGLOBULIN HEAVY CHAIN; GENES, MYC; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MULTIPLE MYELOMA; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 44349090331     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20563     Document Type: Article

References (27)

1. Annunziata CM, Davis RE, Dcmchenko Y, Bellamy W, Gabrea A, Zhan F, Lenz G, Hanamura I, Wright G, Xiao W, Dave S, Hurt EM, Tan B, Zhao H, Stephens O, Santra M, Williams DR, Dang L, Barlogie B, Shaughnessy JD Jr, Kuehl WM, Staudt LM. 2007. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12:115-130.
2. Avet-Loiseau H, Daviet A, Brigaudeau C, Callet-Bauchu E, Terre C, Lafage-Pochitaloff M, Desangles F, Ramond S, Talmant P, Bataille R. 2001a. Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: A study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytogenetique Hematologique. Blood 97:822-825.
3. Avet-Loiseau H, Gerson F, Margrangeas F, Minvielle S, Harousseau J-L, Bataille R. 2001b. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. Blood 98:3082-3086.
4. Avet-Loiseau H, Facon T, Grosbois B, Magrangeas F, Rapp MJ, Harousseau JL, Minvielle S, Bataille R. 2002. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood 99:2185-2191.
5. Bergsagel PL, Kuehl WM. 2001. Chromosomal translocations in multiple myeloma. Oncogene 20:5611-5622.
6. Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J Jr. 2005. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 106:296-303.
7. Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schrock E, Ried T, Kuehl WM. 1998a. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91:4457-4463.
8. Chcsi M, Nardini E, Lim RSC, Smith KD, Kuehl WM, Bergsagel PL. 1998b. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 92:3025-3034.
9. Chng WJ, Ketterling RP, Fonseca R. 2006. Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma. Genes Chromosomes Cancer 45:1111-1120.
10. Chng WJ, Kumar S, Vanwicr S, Ahmann G, Price-Troska T, Henderson K, Chung TH, Kim S, Mulligan G, Bryant B, Carpten J, Gertz M, Rajkumar SV, Lacy M, Dispenzieri A, Kyle R, Greipp P, Bergsagel PL, Fonseca R. 2007. Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling. Cancer Res 67:2982-2989.
11. Dib A, Gabrea A, Glebov O, Bergsagel PL, Kuehl WM. Characterization of MYC translocations in multiple myeloma cell lines. J Natl Cancer Inst (in press).
12. Fonseca R, Bailey RJ, Ahmann GJ, Rajkumar SV, Hoyer JD, Lust JA, Kyle RA, Gertz MA, Greipp PR, Dewald GW. 2002. Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood 100:1417-1424.
13. Fonseca R, Blood E, Rue M, Harrington D, Oken MM, Kyle RA, Dewald GW, Van Ness B, Van Wier SA, Henderson KJ, Bailey RJ, Greipp PR. 2003a. Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood 101:4569-4575.
14. Fonseca R, Debes-Marun CS, Picken EB, Dewald GW, Bryant SC, Winkler JM, Blood E, Oken MM, Santana-Davila R, Gonzalez-Paz N, Kyle RA, Gertz MA, Dispenzieri A, Lacy MQ, Greipp PR. 2003b. The recurrent IgH translocations are highly associated with non-hyperdiploid variant multiple myeloma. Blood 102:2562-2567.
15. Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, Davies FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD Jr, Stewart AK, Avet-Loiseau H. 2004. Genetics and cytogenetics of multiple myeloma: A workshop report. Cancer Res 64:1546-1558.
16. Gabrea A, Bergsagel PL, Chesi M, Shou Y, Kuehl WM. 1999. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. Mol Cell 3:119-123.
17. Gabrea A, Leif Bergsagel P, Michael Kuehl W. 2006. Distinguishing primary and secondary translocations in multiple myeloma. DNA Repair 5:1225-1233.
18. Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ, Van Wier S, Tiedemann R, Shi CX, Sebag M, Braggio E, Henry T, Zhu YX, Fogle H, Price-Troska T, Ahmann G, Mancini C, Brents LA, Kumar S, Greipp P, Dispenzieri A, Bryant B, Mulligan G, Bruhn L, Barrett M, Valdez R, Trent J, Stewart AK, Carpten J, Bergsagel PL. 2007. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 12:131-144.
19. Kuehl WM, Bergsagel PL. 2002. Multiple myeloma: Evolving genetic events and host interactions. Nat Rev Cancer 2:175-187.
20. Lewis JP, MacKenzie MR. 1984. Non-random chromosomal aberrations associated with multiple myeloma. Hematol Oncol 2:307-317.
21. Kuehl M, Shaughnessy JD. Sawyer JR, Lukacs JL, Munshi N, Desikan KR, Singhal S, Mehta J, Siegel D, Shaughnessy J, Barlogie B. 1998. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping. Blood 92:4269-4278.
22. Sawyer JR, Lukacs JL, Thomas EL, Swanson CM, Goosen LS, Sammartino GJCG, Munshi NC, Tricot G, Shaughnessy JD Jr, Barlogie B. 2001. Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma. Brit J Haematol 112:167-174.
23. Shaughnessy J, Gabrea A, Qi Y, Brents LA, Zhan F, Tian E, Sawyer J, Barlogie B, Bergsagel PL, Kuehl WM. 2001. Cyclin D3 at 6p21 is dysregulated by recurrent Ig translocations in multiple myeloma. Blood 98:217-223.
24. Shou Y, Martelli ML, Gabrea A, Qi Y, Brents LA, Roschke A, Dewald G, Kirsch IR, Bergsagel PL, Kuehl WM. 2000. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma. Proc Natl Acad Sci USA 97:228-233.
25. Smadja NV, Bastard C, Brigaudeau C, Leroux D, Fruchart C. 2001. Hypodiploidy is a major prognostic factor in multiple myeloma. Blood 98:2229-2238.
26. Smadja NV, Fruchart C, Isnard F, Louvet C, Dutel JL, Cheron N, Grange MJ, Monconduit M, Bastard C. 1998. Chromosomal analysis in multiple myeloma: Cytogenetic evidence of two different diseases. Leukemia 12:960-969.
27. Smadja NV, Leroux D, Soulier J, Dumont S, Arnould C, Taviaux S, Taillemite JL, Bastard C. 2003. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases. Genes Chromosomes Cancer 38:234-239.